Birth Asphyxia: Walter Otieno Consultant Paediatrician

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 21

Birth asphyxia

Walter Otieno
Consultant Paediatrician
Objectives
• Understand the assessment & care of normal
birth
• Familiar with the pathogenesis of birth asphyxia
• Know Apgar score & ABCDE resuscitation
• Familiar with the complication of severe
asphyxia
Background
• Birth asphyxia is defined as a reduction of oxygen delivery
and an accumulation of carbon dioxide owing to cessation of
blood supply to the fetus around the time of birth.

• This is pathologic condition referred to neonate who have no


spontaneous breathing or represented irregular breathing
movement after birth. Usually caused by perinatal hypoxia. It
is emergency condition and need quickly treatment
(resuscitation)
Criteria for asphyxia

Intrapartum distress, as indicated by:


– fetal bradycardia
– meconium-stained amniotic fluid
– an Apgar score of 6 or less at five minutes
– need ventilation and oxygen immediately after
birth
– blood pH value of 7.20 or less
Aetiology
 Pathologically, any factors which interfere with the circulation between
maternal and fetal blood exchange could result in perinatal asphyxia.
These factors can be maternal factor, delivery factor and fetal factor
• Maternal factor:
Maternal illness (anemia, diabetes, nephritis, heart disease), maternal
infection, PROM, PIH, APH, substance abuse,
• Delivery condition:
Abruption of placenta, placenta previa, prolapsed cord, premature
rupture of membranes, sedative drugs
• Fetal factor:
Multiple birth, congenital or malformed fetus, prolonged labor,
intrauterine infections.
Pathophysiology

Hypoxic cellular damages:


a. Reversible damage(early stage):

Hypoxia may decrease the production of ATP, and result in the


cellular functions . But these change can be reversible if hypoxia is
reversed in short time.

b. Unreversible damage:

If hypoxia exist in long time enough, the cellular damage will become
unreversible that means even if hypoxia disappear but the cellular
damages are not recovers. In other words, the complications will happen.
Pathophysiology
Primary apnea
Breathing stop but normal muscular tone or hypertonia, tachycardia and
hypertension

Secondary apnea

Features of severe asphyxia or unsuccessful resuscitation, usually result in

damage of organs function.

Other damages:

a. Persistent pulmonary hypertension (PPHN)

b. Hyper/hypoglycemia

c. Hyperbilirubinemia
Clinical manifestations
fetal heart rate: tachycardia then bradycardia

fetal movement: increase then decrease

amniotic fluid: meconium-stained

APGAR SCORE
Score 0 1 2
Heart rate none <100 > 100
Respiration none irregular regular
Muscle tone limp reduced normal
Response to none grimaced cough
stimulation
Color of trunk white blue pink
Degree of asphyxia:

Apgar score 8~10: no asphyxia

Apgar score 4~8: mild/cyanosis asphyxia

Apgar score 0~3: severe/pale asphyxia


Complications
CNS: HIE, ICH
• RS: MAS, RDS, pulmonary hemorrhage, persistent
fetal circulation, pulmonary hypertension
• CVS: myocardial injury, heart failure, cardiac shock
• GIS: NEC, stress ulcer
• Kidneys: Acute renal failure, renal venous
thrombosis, Acute tubular necrosis
• Others: hypoglycemia, hypocalcemia, hyponatremia
Diagnosis

Evidence of fetal distress

Fetal metabolic acidosis

Abnormal neurological state

Multiorgan involvement
Management
• ABCDE resuscitation
• A (air way)
• B (breathing)
• C (circulation)
• D (drug)
• E (evaluation)
Basic algorithm for newborn resuscitation
Drugs
profound bradycardia, give adrenaline (1:10000, 0.1-
0.3ml/kg) by endotracheal tube or umbilical vein

if no response, intravenous fluid (saline, albumin,


plasma, blood) with 10ml/kg

if acidosis, give 5% sodium bicarbonate with 3-5ml/kg

if bradypnea, consider using naloxone (0.1mg/kg)


Hypoxic Ischemic Encephalopathy
(HIE)
• The brain damage after perinatal asphyxia and
the most severe condition showed high
mortality or remain cerebral complications
such as mental retardation & cerebral palsy.
Pathophysiology
• Cerebral blood flow
early stage: normal (intraorgans shunt)
then slow down (selective vulnerability)
finally ischemia
• Cerebral metabolism
Clinical manifestations

Excitation: hyperalert, irritable, hypertonia,


tachycardia, tachypnea, seizure, etc

Depression: coma, hypotonia, bradycardia,


bradypnea, unresponsibility, etc
Classification

• Mild(stage I): hyperalert, irritable, normal muscular


tone & reflex, no seizure, normal EEG

• Moderate(stage II): lethargy, hypotonia, weak


sucking & Moro response, often seizure, EEG+

• Severe(stage III): coma, absent muscular tone &


reflex, persistent seizure, EEG++
Management

Generalized treatment:
– Ventilation: CPAP, CMV, HFOV
– Circulation: Dopamine/Dobutamine
– Energy: normal glucose
– Fluid: restriction < 60-80ml/kg/d
Management
Control of seizures:
– Phenobarbital
loading dose 15-20mg/kg, iv maintenance dose 3-5mg/kg, iv

Cerebral edema & high pressure

– Furosemide , Mannitol 0.5g/kg, iv, q8-12h


Prognosis
• Depends on severity

You might also like